Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

Total article views   HTML views PDF downloads Totals
9,662 Dovepress* 8,804+ 1,279 10,083
PubMed Central* 858 268 1,126
Totals 9,662 1,547 11,209
*Since 5 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar